Is a vaccine necessary with up to 99-100% effective treatments for COVID?

[admin]

Please read the important disclaimer at the following link before proceeding further on this page. The administrator of this forum is not a doctor nor licensed or experienced in any aspect of the health care industry.
https://www.covid-19forum.org/index.php?topic=227.0

[edit addition 7-30-21] Even according to this meta-analysis by the biased NIH (conflict of interest vaccine patent holder and profiteer): 
"The estimated age-specific IFR [infection fatality rate for COVID-19] is very low for children and younger adults (e.g., 0.002% at age 10 [that's 2 out of 100,000 kids] and 0.01% at age 25 [that's 1 out of 10,000 young people]) but increases progressively to 0.4% at age 55 [4 out of 1,000], 1.4% at age 65, 4.6% at age 75, and 15% at age 85."
Or, when considered in a less hysterical and more traditional pre-COVID light, "Pneumonia is an old man's friend".

However, it is important to recognize that because of fraudulent testing along with power-seeking and financial incentives to falsely diagnose, it would seem that well over 90% of COVID-19 diagnoses were actually influenza A or B.
https://www.covid-19forum.org/index.php?topic=747.0
https://www.covid-19forum.org/index.php?topic=657.0
https://www.covid-19forum.org/index.php?topic=473.0
It is even more important to not only recognize that the overwhelming majority of the deaths were in high-risk patients with multiple comorbidities, but that well over 99% of even those cases could have been saved through an early treatment protocol utilizing ivermectin or hydroxychloroquine in the hands of a competent, compassionate, medical professional:
https://www.covid-19forum.org/index.php?topic=359.0
In other words, nobody had to die. [end edit]
________________________________________________

But to be up to 99-100% effective, treatment protocols using ivermectin or hydroxychloroquine need to be administered early, upon presentation of symptoms or clinical suspicion of COVID-19. Like all disease, the longer COVID-19 is allowed to run, the less effective treatment will be. And particularly so with antivirals.
https://www.covid-19forum.org/index.php?board=3.0 [end edit]

By fall of 2020 Dr. Brian Tyson and his team had successfully treated over 1,700 elderly and high-risk patients, with 0 deaths and only 1 hospitalization of 4 days. Does that suggest a need for a vaccine?
https://www.covid-19forum.org/index.php?topic=359.0

At the 20:20 mark Dr Ryan Cole describes how mRNA vaccines, would never have been able to be defined as vaccines, until the definition was changed in order to roll out the novel mRNA "vaccines".

[edit add 7-2-21] Noticed that youtube banned the video in the player. Here's the bitchute version:
https://www.bitchute.com/video/BL4n6gdsA18e/ [end edit]



50-year old Ivermectin is one drug that would seem to render a vaccine unnecessary:
https://www.covid-19forum.org/index.php?topic=461.0

As a preventative/prophylaxis Dr. Pierre Kory declares:  "If you are taking Ivermectin you will not contract COVID-19. I repeat, if you are taking Ivermectin you will not contract COVID-19."

[edit add 7-23-21] As we can witness in the player below, Google/YouTube even banned congressional testimony by a board certified intensive care unit pulmonologist when it didn't fit Anthony Fauci's, essentially, go home and die recommendation for early treatment of COVID-19. Anybody that depends on Google/YouTube for information cannot have any interest in truth. (Anti)social and legacy media lies and Big Tech censorship have resulted in the completely unnecessary deaths of well over a half a million Americans and millions more around the world.
Fortunately the video can still be accessed at BitChute on this link:
https://www.bitchute.com/video/NSil15MibqlM/ [end edit]



Scroll to 27 minute mark for the model for treatment to end the pandemic and why "Big Science" prevented the pandemic from ending a year ago.





Edit 1-28: While there is no FDA approved vaccine for COVID-19, we can all hope that the next few years demonstrate the COVID vaccine to be safe (it sometimes takes 5-7 years before a vaccine is widely accepted) and won't result in "pathogenic priming" or an "enhanced immune response", even though it is currently being administered to the elderly even though it was only tested on younger healthy individuals.
____________________________________

Is a vaccine necessary when there are COVID treatment protocols that are up to 99-100% effective in the EARLY outpatient setting, one of which is even more effective as prophylaxis for COVID-19? This single thread should render the whole subject of a COVID vaccine irrelevant, and the content of this entire forum category moot.

If the above video becomes censored by Google/YouTube and Facebook, as so many have been by world leading virologists and epidemiologists in social media's advancement of genocide, part of it can still be accessed on BitChute at this link:
https://www.bitchute.com/video/oKd6wrjER8Lc/
___________________________________________________

When Google/YouTube censors this video you can access it at the bitchute link below the video player.



Video by study authors:
https://www.bitchute.com/video/L7B8UJ2lGGGI/

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3765018

"Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

15 Pages Posted: 21 Jan 2021 Last revised: 27 Jan 2021
Juan J Chamie-Quintero

Universidad EAFIT
Jennifer Hibberd

University of Toronto
David Scheim

US Public Health Service

Date Written: January 12, 2021
Abstract

On May 8, 2020, Peru’s Ministry of Health approved ivermectin (IVM) for the treatment of COVID-19. A drug of Nobel Prize-honored distinction, IVM has been safely distributed in 3.7 billion doses worldwide since 1987. It has exhibited major, statistically significant reductions in case mortality and severity in 11 clinical trials for COVID-19, three with randomized controls. The indicated biological mechanism of IVM is the same as that of antiviral antibodies generated by vaccines—binding to SARS-CoV-2 viral spike protein, blocking viral attachment to host cells.

Mass distributions of IVM for COVID-19 treatments, inpatient and outpatient, were conducted in different timeframes with local autonomy in the 25 states (departamentos) of Peru. These treatments were conducted early in the pandemic’s first wave in 24 states, in some cases beginning even a few weeks before the May 8 national authorization, but delayed four months in Lima. Analysis was performed using Peruvian public health data for all-cause deaths and for COVID-19 case fatalities, as independently tracked for ages 60 and above. These daily figures were retrieved and analyzed by state. Case incidence data were not analyzed due to variations in testing methods and other confounding factors. These clinical data associated with IVM treatments beginning in different time periods, April through August 2020, in each of 25 Peruvian states, spanning an area equivalent to that from Denmark to Italy and Greece in Europe or from north to south along the US, with a total population of 33 million, provided a rich source for analysis.

For the 24 states with early IVM treatment (and Lima), excess deaths dropped 59% (25%) at +30 days and 75% (25%) at +45 days after day of peak deaths. Case fatalities likewise dropped sharply in all states but Lima, yet six indices of Google-tracked community mobility rose over the same period. For nine states having mass distributions of IVM in a short timeframe through a national program, Mega-Operación Tayta (MOT), excess deaths at +30 days dropped by a population-weighted mean of 74%, each drop beginning within 11 day after MOT start. Extraneous causes of mortality reductions were ruled out. These sharp major reductions in COVID-19 mortality following IVM treatment thus occurred in each of Peru’s states, with such especially sharp reductions in close time conjunction with IVM treatments in each of the nine states of operation MOT. Its safety well established even at high doses, IVM is a compelling option for immediate, large scale national deployments as an interim measure and complement to pandemic control through vaccinations.

Note: Funding: This paper received no funding.

Declaration of Interests: None of the three authors of this paper have any competing interest, no financial interests at all, relevant to the subject or conclusions of this paper.

Keywords: ivermectin, COVID-19, SARS-CoV-2, spike protein, Peru

Suggested Citation"

Video by study authors:
https://www.bitchute.com/video/L7B8UJ2lGGGI/

https://www.covidtreatmentoptions.com/#ivermectin


______________________________________________________________

Dr. Paul Marik on ivermectin.



Is risking receiving - particularly a rushed vaccine - necessary, when ever since March there has been a treatment protocol that has been shown to be 99-100% effective even among elderly and high-risk individuals when administered early (upon presentation of symptoms or suspicion of COVID-19), that could also keep about 90+% of COVID-19 patients from ever being hospitalized?
https://www.covid-19forum.org/index.php?topic=18.0

Our death rate from COVID-19 could theoretically be reduced from the current rate of 700-900 per day to just 7-9 per day at 1%, if the Zelenko Protocol were adopted and administered universally across the U.S. by competent clinicians and if all patients received it when needed. That reduction in the death rate could transpire within 2 weeks time as the accidental reverse Swiss model demonstrated:
https://www.covid-19forum.org/index.php?topic=18.msg384#msg384



Dr. Brian Tyson risk stratified patients and then treated 1900 elderly and high-risk individuals with 0 deaths and only 1 hospitalization of 4 days. Dr. Vladimur Zelenko had 99.75% success over 800 elderly and high-risk patients. So wouldn't that suggest that seeking a vaccine for something, that is 100% curable in the early outpatient setting with $20 treatment protocols, goes beyond unnecessary and into unnecessarily dangerous?

[admin]

100% of early outpatients treated successfully with zero hospitalizations. No more need for vaccine than we do for MERS or Sars1.
https://www.bitchute.com/video/PbZTlxaEb2oP/

https://video.parler.com/1o/OO/1oOO44n5m8dz.mp4?fbclid=IwAR0uNt4DzoFaGIeuN7CEj0I5np2pUa0csArz80YpgSaoCqLTCrU9pd1xj-k

[admin]

https://brandnewtube.com/watch/must-watch-kate-shemirani-vaccines-on-healthcare-staff_nktoQdQn7Ti5pID.html

https://www.linkedin.com/pulse/need-vaccines-covid-pandemic-over-says-former-vice-president-soans

"No need for vaccines, COVID pandemic is over, says Former Vice President of Pfizer
Published on November 28, 2020

The former Vice President and Chief Scientist of Pfizer Dr. Michael Yeadon has said that there is no need for any vaccines to bring the COVID-19 pandemic to an end.

According to Dr. Michael Yeadon, “There is absolutely no need for vaccines to extinguish the pandemic. I’ve never heard such nonsense talked about vaccines. You do not vaccinate people who aren’t at risk from a disease. You also don’t set about planning to vaccinate millions of fit and healthy people with a vaccine that hasn’t been extensively tested on human subjects.”

His comments come at the end of a comprehensive criticism of the Scientific Advisor Group for Emergencies (SAGE), a government agency of the U.K. tasked with advising the central government in emergencies.

SAGE has played an important role in determining public lockdown policies in the UK, as a response to the COVID-19 virus.

Dr. Michael Yeadon also highlights fundamental errors by SAGE in their presuppositions which cause their overall conclusions to go radically awry leading to the “torturing the population for the last seven months or so.”

“SAGE says everyone was susceptible and only 7% have been infected. I think this is literally unbelievable. They have ignored all precedent in the field of immunological memory against respiratory viruses. They have either not seen or disregarded excellent quality work from numerous, world-leading clinical immunologists which show that around 30% of the population had prior immunity.”

“They should also have excluded from ‘susceptible’ a large subset of the youngest children, who appear not to become infected, probably because their immature biology means their cells express less of the spike protein receptor, called ACE2. I have not assumed all young children don’t participate in transmission, but believe a two thirds value is very conservative. It’s not material anyway,” Dr. Michael Yeadon wrote.

“So SAGE is demonstrably wrong in one really crucial variable: they assumed no prior immunity, whereas the evidence clearly points to a value of around 30% (and nearly 40% if you include some young children, who technically are ‘resistant’ rather than ‘immune’),” wrote Dr. Michael Yeadon.

And considering the reality of herd immunity, when susceptibility to a virus falls this low, at around 28 to 35%, “that population can no longer support an expanding outbreak of disease,” and thus the virus “wanes and disappears.”

“The pandemic is effectively over and can easily be handled by a properly functioning NHS (National Health Service). Accordingly, the country should immediately be permitted to get back to normal life.” concludes Dr. Michael Yeadon

https://www.nationalheraldindia.com/health/no-need-for-vaccines-the-covid-pandemic-is-over-says-former-vice-president-of-pfizer

[admin]

When Google/YouTube censors this video you can access it at the bitchute link below the video player.



Video by study authors:
https://www.bitchute.com/video/L7B8UJ2lGGGI/

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3765018

"Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

15 Pages Posted: 21 Jan 2021 Last revised: 27 Jan 2021
Juan J Chamie-Quintero

Universidad EAFIT
Jennifer Hibberd

University of Toronto
David Scheim

US Public Health Service

Date Written: January 12, 2021
Abstract

On May 8, 2020, Peru’s Ministry of Health approved ivermectin (IVM) for the treatment of COVID-19. A drug of Nobel Prize-honored distinction, IVM has been safely distributed in 3.7 billion doses worldwide since 1987. It has exhibited major, statistically significant reductions in case mortality and severity in 11 clinical trials for COVID-19, three with randomized controls. The indicated biological mechanism of IVM is the same as that of antiviral antibodies generated by vaccines—binding to SARS-CoV-2 viral spike protein, blocking viral attachment to host cells.

Mass distributions of IVM for COVID-19 treatments, inpatient and outpatient, were conducted in different timeframes with local autonomy in the 25 states (departamentos) of Peru. These treatments were conducted early in the pandemic’s first wave in 24 states, in some cases beginning even a few weeks before the May 8 national authorization, but delayed four months in Lima. Analysis was performed using Peruvian public health data for all-cause deaths and for COVID-19 case fatalities, as independently tracked for ages 60 and above. These daily figures were retrieved and analyzed by state. Case incidence data were not analyzed due to variations in testing methods and other confounding factors. These clinical data associated with IVM treatments beginning in different time periods, April through August 2020, in each of 25 Peruvian states, spanning an area equivalent to that from Denmark to Italy and Greece in Europe or from north to south along the US, with a total population of 33 million, provided a rich source for analysis.

For the 24 states with early IVM treatment (and Lima), excess deaths dropped 59% (25%) at +30 days and 75% (25%) at +45 days after day of peak deaths. Case fatalities likewise dropped sharply in all states but Lima, yet six indices of Google-tracked community mobility rose over the same period. For nine states having mass distributions of IVM in a short timeframe through a national program, Mega-Operación Tayta (MOT), excess deaths at +30 days dropped by a population-weighted mean of 74%, each drop beginning within 11 day after MOT start. Extraneous causes of mortality reductions were ruled out. These sharp major reductions in COVID-19 mortality following IVM treatment thus occurred in each of Peru’s states, with such especially sharp reductions in close time conjunction with IVM treatments in each of the nine states of operation MOT. Its safety well established even at high doses, IVM is a compelling option for immediate, large scale national deployments as an interim measure and complement to pandemic control through vaccinations.

Note: Funding: This paper received no funding.

Declaration of Interests: None of the three authors of this paper have any competing interest, no financial interests at all, relevant to the subject or conclusions of this paper.

Keywords: ivermectin, COVID-19, SARS-CoV-2, spike protein, Peru

Suggested Citation"

Video by study authors:
https://www.bitchute.com/video/L7B8UJ2lGGGI/

https://www.covidtreatmentoptions.com/#ivermectin

[admin]

55 People Have Died in US After Receiving COVID-19 Vaccines: Reporting System
By Zachary Stieber
January 16, 2021 Updated: January 17, 2021
biggersmaller Print

Fifty-five people in the United States have died after receiving a COVID-19 vaccine, according to reports submitted to a federal system.

Deaths have occurred among people receiving both the Moderna and the Pfizer-BioNTech vaccines, according to the Vaccine Adverse Event Reporting System (VAERS), a federal database. The system is passive, meaning reports aren’t automatically collected and must be filed. VAERS reports can be filed by anyone, including health care providers, patients, or family members.

VAERS reports “often lack details and sometimes can have information that contains errors,” according to the reporting system’s website. Still, reports on VAERS represent “only a small fraction of actual adverse events,” the site states, although underreporting is believed to be less common for serious events.

In some cases, patients died within days of being vaccinated.

One man, a 66-year-old senior home resident in Colorado, was sleepy and stayed in bed the day after getting Moderna’s vaccine. Early the next morning, he “was observed in bed lying still, pale, eyes half open and foam coming from mouth and unresponsive,” the VAERS report states. “He was not breathing and with no pulse.”

In another case, a 93-year-old South Dakota man was injected with the Pfizer-BioNTech vaccine on Jan. 4 around 11 a.m. About two hours later, he said he was tired and couldn’t continue with the physical therapy he was doing. He was taken back to his room, where he said his legs felt heavy. Soon after, he stopped breathing. A nurse declared a do-not-resuscitate order.

While Moderna and Pfizer didn’t immediately respond to requests for comment, Abigail Capobianco, a spokeswoman for the Food and Drug Administration (FDA), told The Epoch Times via email, “Any reports of death following the administration of vaccines are promptly and rigorously investigated jointly by FDA” and the Centers for Disease Control and Prevention (CDC).

Officials at the agencies work with health care providers to obtain medical histories and clinical follow-up information and conduct a clinical case review, she said, adding, “It is important to note that it is generally not possible to find out from VAERS data if a vaccine caused an adverse event.”

Health officials on the VAERS website caution that a report to the system doesn’t prove a vaccine caused the adverse event; proof that the event was caused by the vaccine is not required in order for the system to accept the report.
vaccine bottle
A COVID-19 vaccine vial in New York City on Jan. 4, 2021. (Shannon Stapleton/Pool/AFP via Getty Images)

In addition to the deaths, people have reported 96 life-threatening events following COVID-19 vaccinations, as well as 24 permanent disabilities, 225 hospitalizations, and 1,388 emergency room visits.

Neither the CDC nor the FDA has a central database of reported adverse events. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, said on Jan. 6 that severe allergic reactions to COVID-19 vaccines were happening at a rate of 11.1 per million vaccinations, compared to the rate of 1.3 per million flu shots.

As of Jan. 15, 10.5 million Americans have received a COVID-19 vaccine. Federal health officials have said that adverse events are being investigated but that the vaccines are still safe.

“These are safe and effective vaccines. We have good data to show that,” Messonnier said.

One death following a vaccination attracted attention earlier this week. Gregory Michael, a 56-year-old medical worker at Mount Sinai Medical Center in Miami, was injected on Dec. 18, 2020. Sixteen days later, he died.

Michael’s wife Heidi Neckelmann said on Facebook that her husband was “very healthy” before being vaccinated. She said he was admitted to an intensive care unit with a diagnosis of acute idiopathic thrombocytopenic purpura, a blood disorder, allegedly caused by a reaction to the vaccine. He eventually died.

“He was a pro-vaccine advocate, that is why he got it himself,” Neckelmann wrote. “I believe that people should be aware that side effects can happen, that it is not good for everyone, and in this case destroyed a beautiful life, a perfect family, and has affected so many people in the community. Do not let his death be in vain, please save more lives by making this information news.”

Pfizer told news outlets in a statement that no evidence currently shows a link between that death and its vaccine.

“Pfizer and BioNTech are aware of the death of a health care professional 16 days after receiving a first dose of BNT162b2,” Pfizer said in a statement. “It is a highly unusual clinical case of severe thrombocytopenia, a condition that decreases the body’s ability to clot blood and stop internal bleeding.”

“We are actively investigating this case, but we don’t believe at this time that there is any direct connection to the vaccine,” the company said. “There have been no related safety signals identified in our clinical trials, the post-marketing experience thus far, or with the mRNA vaccine platform. To date, millions of people have been vaccinated and we are closely monitoring all adverse events in individuals receiving our vaccine. It is important to note that serious adverse events, including deaths that are unrelated to the vaccine, are unfortunately likely to occur at a similar rate as they would in the general population.”

A Pfizer spokesperson told The Epoch Times via email earlier this month that the company “closely monitor[s ] all reports following vaccination.” Moderna hasn’t responded to requests for comment on its involvement in monitoring serious adverse events in people who get its vaccine.

The updated VAERS data came after Norway changed its COVID-19 vaccination guide to direct officials not to give “very frail” people the vaccines, citing 13 deaths among people who were vaccinated.
Follow Zachary on Twitter: @zackstieber

[admin]

Please understand that the deaths attributed to COVID-19 in the chart below are, by and large, fraudulently inflated by as much as 80%.
https://noqreport.com/2021/04/20/cdc-violated-law-to-inflate-covid-cases-and-fatalities/

https://www.statmap.org/

[admin]

https://flattenthefear.com/

[admin]

[admin]

bump